This work aims at
studying how the transformations that magnetic
nanoparticles suffer in vivo affect their heating properties in the
frame of hyperthermia treatments. Iron oxide magnetic nanoparticles
(≈13 nm) with two different coatings [PMAO (polymaleic anhydride-alt-1-octadecene) and DMSA (dimercaptosuccinic acid)] have
been subjected to an accelerated degradation in a medium simulating
lysosome conditions. The particles physicochemical properties (size,
size distribution, and magnetic properties) have been followed over
the degradation process along 24 days. It was found that DMSA-coated
particles degraded much faster than PMAO-coated ones. In addition,
their heating properties under both the exposure to an alternating
magnetic field or a near infrared light have been tracked along this
degradation processes, assessing how the changes in their physicochemical
properties affect their heating capacity. Along the degradation procedure,
a stronger decrease of the particles heating properties has been observed
in the frame of magnetic hyperthermia measurements, in comparison
with the photothermal ones. Finally, the PMAO-coated particles have
been selected for a degradation study in vivo after intratumoral administration.
Interestingly, although the number of particles decreases with time
in the tissue, the size and size distribution of the particles do
not change significantly over time. This work is especially relevant
in the frame of the design of in vivo hyperthermia treatments using
magnetic nanoparticles as it would provide fundamental clues regarding
the need of repeated doses or the possible use of a single administration
depending on the treatment duration.